Skip to content
S2976Senate2021-2022 SessionSame asA348

Give Narcan to Discharged Patients

Official title

“Relates to providing discharged patients with opioid overdose education and opioid antagonists for take home use”

Sponsor Pete HarckhamSD-40+2 co-sponsorsAffects Health
Status
Vetoed
Impact
6/10
Moderate
Outcome
Vetoed

Bill progress

Vetoed

What's happening

This bill requires discharged patients and formerly incarcerated individuals with substance use disorders to receive educational materials and two doses of an opioid antagonist for take-home use.

Why it matters

  1. Aims to reduce the risk of fatal opioid overdoses. by ensuring people most at risk—those recently discharged from treatment, hospitals, or incarceration—have immediate access to life-saving opioid antagonists (e.g., naloxone) when they return to the community.

  2. Addresses a critical period of vulnerability. , since individuals leaving treatment programs, hospitals, or correctional facilities face heightened overdose risk due to possible reduced tolerance and increased likelihood of relapse.

  3. Standardizes essential overdose education and medication access. across hospitals, addiction treatment programs, and correctional facilities, potentially reducing disparities in care and improving public health outcomes for those with substance use disorders.

  4. Shifts some financial and logistical responsibility to institutions. (hospitals, treatment centers, and correctional facilities), which may require new resources or protocols but could ultimately save lives and reduce emergency healthcare burdens.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • OASAS-operated and licensed treatment programs

    They would have to provide patients diagnosed with a substance use disorder with educational materials and two take-home doses of an opioid antagonist when discharged or conditionally released.

  • State and local correctional facilities

    They would have to provide educational materials and two take-home doses of an opioid antagonist upon release to individuals whose facility records show a substance use disorder diagnosis made while incarcerated there.

  • Hospitals and emergency departments

    Hospitals would have to provide two take-home doses of an opioid antagonist at treatment commencement, admission or discharge to individuals with a documented substance use disorder or who appear to have or be at risk for one.

  • People with substance use disorders leaving treatment or incarceration

    Eligible individuals would receive overdose-reversal medication and educational materials to take with them upon release.

Headline styles

Give Narcan to Discharged Patients

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Pete Harckham

Senator · Senate District 40

Chair, Alcoholism And Substance Abuse

History

  1. Vetoed memo.159
  2. Delivered to governor
  3. Returned to senate
  4. Passed assembly
  5. Ordered to third reading rules cal.170
  6. Substituted for A348A
  7. Referred to alcoholism and drug abuse
  8. Delivered to assembly
  9. Passed senateVote 62–1
  10. Amended on third reading (t) 2976a
  11. Advanced to third reading
  12. 2nd report cal.
Show 11 earlier actions
  1. 1st report cal.308
  2. Referred to alcoholism and substance abuse
  3. Returned to senate
  4. Died in assembly
  5. Referred to alcoholism and drug abuse
  6. Delivered to assembly
  7. Passed senateVote 58–5
  8. Advanced to third reading
  9. 2nd report cal.
  10. 1st report cal.439
  11. Referred to alcoholism and substance abuse

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A348Assembly

Give Naloxone to Discharged Patients

Assembly Floor Calendar · Sponsor Edward Braunstein

Impact 6 · Moderate0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

2976--A Cal. No. 308

2021-2022 Regular Sessions

IN SENATE

January 26, 2021

Introduced by Sens. HARCKHAM, HINCHEY -- read twice and ordered printed, and when printed to be committed to the Committee on Alcoholism and Substance Abuse -- recommitted to the Committee on Alcoholism and Substance Abuse in accordance with Senate Rule 6, sec. 8 -- reported favorably from said committee, ordered to first and second report, ordered to a third reading, amended and ordered reprinted, retaining its place in the order of third reading

AN ACT to amend the mental hygiene law, in relation to providing discharged patients with certain educational materials regarding substance use disorders and two doses of an opioid antagonist in a form approved for take home use; to amend the correction law,… Show all

AN ACT to amend the mental hygiene law, in relation to providing discharged patients with certain educational materials regarding substance use disorders and two doses of an opioid antagonist in a form approved for take home use; to amend the correction law, in relation to providing previously incarcerated individuals with certain educational materials regarding substance use disorders and two doses of an opioid antagonist in a form approved for take home use upon discharge from incarceration; and to amend the public health law, in relation to the provision of opioid antagonists for take home use upon discharge from the hospital

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The mental hygiene law is amended by adding a new section 32.40 to read as follows: § 32.40 Educational materials for individuals with substance use disor-

ders.

(a) An individual discharged or conditionally released from a treatment program operated or licensed by the office of addiction services and supports who has been diagnosed with a substance use disorder shall be provided with education materials that are consistent with educational materials provided pursuant to subdivision one of section twenty-eight hundred three-u of the public health law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD03415-03-2

(b) Such program shall also provide the individual with two doses of an opioid antagonist in a form approved for take home use by the federal food and drug administration when the individual is leaving the program.

§ 2. The correction law is amended by adding a new section 149-a to read as follows:

§ 149-a. Previously incarcerated individuals with a substance use disorder. The department shall require each correctional facility to provide incarcerated individuals who, according to the records of the department, have been diagnosed with a substance use disorder while at such facility with the following upon release: (i) educational materials consistent with subdivision one of section twenty-eight hundred three-u of the public health law; and (ii) two doses of an opioid antagonist in a form approved for take home use by the federal food and drug administration.

§ 3. The correction law is amended by adding a new section 511 to read as follows:

§ 511. Previously incarcerated individuals with a substance use disorder. The commissioner shall require each local correctional facility to provide incarcerated individuals who, according to the records of the jail, have been diagnosed with a substance use disorder while at such facility with the following upon release:

1. educational materials consistent with subdivision one of section twenty-eight hundred three-u of the public health law; and

2. two doses of an opioid antagonist in a form approved for take home use by the federal food and drug administration.

§ 4. Subdivision 3 of section 2803-u of the public health law, as added by section 1 of part C of chapter 70 of the laws of 2016, is amended to read as follows:

3. Upon commencement of treatment, admission, or discharge of an individual with a documented substance use disorder or who appears to have or be at risk for a substance use disorder, including discharge from the emergency department, such hospital shall: (a) inform the individual of the availability of the substance use disorder treatment services that may be available to them through a substance use disorder services program; and (b) provide the individual with two doses of an opioid antagonist in a form approved for take home use by the federal food and drug administration.

§ 5. This act shall take effect on the one hundred eightieth day after it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the mental hygiene law, in relation to providing discharged patients with certain educational materials regarding substance use disorders and two doses of an opioid antagonist in a form approved for take home use; to amend the correction law, in relation to providing previously incarcerated individuals with certain educational materials regarding substance use disorders and two doses of an opioid antagonist in a form approved for take home use upon discharge from incarceration; and to amend the public health law, in relation to the provision of opioid antagonists for take home use upon discharge from the hospital

Purpose

Relates to providing discharged patients with opioid overdose education and opioid antagonist for take home use.

Summary of provisions

Section 1 adds a new subdivision (o) to Section 32.40 of the mental hygiene law, mandating that a patient about to be discharged or condi- tionally released from an inpatient facility operated or licensed by the Office of Alcoholism and Substance Abuse Services, and who has been diagnosed with an opioid use disorder, shall provide such patient with an opioid overdose education that conforms to the Department of Health or federal Substance Abuse and Mental Health Services Administration Guidelines for opioid education. This education must explain the causes of an opioid overdose, instruct when and how to administer life saving techniques, an opioid antagonist, and how to contact emergency medical services. Such facility shall also provide the patient as they leave the facility with two doses of an opioid antagonist and a prescription for an opioid antagonist.

Read the full memo (1,171 words)

Section 2 amends the correction law by adding a new section 149-a in relation to released inmates with an opioid use disorder. Upon discharge of an inmate who has been diagnosed with an opioid use disorder from a correctional facility, regardless of whether that inmate has received treatment for that disorder, the department shall provide such inmate with an opioid overdose education that conforms to the Department of Health or federal Substance Abuse and Mental Health Services Adminis- tration Guidelines for opioid education. This education must explain the causes of an opioid overdose, instruct when and how to administer life saving techniques, an opioid antagonist, and how to contact emergency medical services. Such facility shall also provide the patient as they leave the facility with two doses of an opioid antagonist and a prescription for an opioid antagonist.

Section 3 amends the correction law by adding a new section 511 in relation to released inmates with an opioid use disorder. Upon discharge of an inmate who has been diagnosed with an opioid use disorder from a correctional facility, regardless of whether that inmate has received treatment for that disorder, the department shall provide such inmate with an opioid overdose education that conforms to the Department of Health or federal Substance Abuse and Mental Health Services Adminis- tration Guidelines for opioid education. Such facility shall also provide the patient as they leave the facility with two doses of an opioid antagonist and a prescription for an opioid antagonist.

Section 4 amends Section 511 of the public health law by mandating that upon commencement of treatment, admission, or discharge of an individual with a documented substance abuse disorder, or who appears to have or be at risk for a substance use disorder, including discharge from the emer- gency department, a hospital shall provide the individual with two doses of an opioid antagonist.

Section 5 contains the effective date.

Justification

Between 2015 and 2016 the opioid overdose death rate in New York State increased by 40%. As of March 2018, more than 115 people in the United States die every day from overdosing on opioids, according to the CDC. Opioid antagonists, such as naloxone, are drugs that reverse the effects of opioids, and are effective in preventing overdose deaths. The avail- ability of an opioid antagonist is crucial in ensuring that overdose deaths do not occur. However, an opioid antagonist can only be effective as an antidote to those readily available when an overdose is happening. In 2018, the United States Surgeon General issued the first national advisory in over a decade, urging all Americans to carry naloxone.

The American College of Emergency Physicians recently reported that "addiction researchers have demonstrated that overdose events are an important indicator not only of future overdoses but also represent a critical opportunity for overdose prevention and engagement in the treatment; those who have overdosed on heroin are four to five times more likely to suffer a subsequent overdose event, and are at higher risk for death from opioid overdose_ since 2004, drug-related emergency department visits increased by over 80%."

A study titled "Peer Navigation and take-home naloxone for opioid over- dose emergency department patients" found "a high frequency of death and repeat overdose one-year following an emergency department visit for opioid overdose." The Maryland Hospital Association recommended in December, 2018 that "hospitals should offer naloxone to patients who present in the emergency department with an opioid overdose and to patients deemed to be at risk for opioid use disorder, by dispensing directly from the emergency department or by providing a prescription."

According to the Harm Reduction Coalition, "individuals with a history of drug use who are leaving jail or prison have a great likelihood of overdosing in the first two weeks following discharge." A North Carolina study published in 2018 by the American Journal of Public Health indi- cated that "in the first two weeks after being released from prison, former inmates were 40 times more likely to die of an opioid overdose than someone in the general population. When restricted to heroin over- doses only, the overdose death rate increased to 74 times the norm with two weeks after release. Even the entire year after release, overdose death rates remained 1018 times higher among formerly incarcerated indi- viduals."

A report in the Journal of Addictive Diseases concluded that "due to the increased risk of overdose following periods of abstinence_ pre-release program of overdose prevention education, including Naloxone prescription, of inmates with a history of opiate addiction would likely prevent many overdose deaths." The study found that many will refuse to call 911 in the event of an overdose, due to fear of police involvement.

In light of these tragic statistics, this bill mandates that inmates, as well as patients about to be discharged from inpatient drug rehabili- tation facilities, who have been diagnosed with an opioid use disorder, receive opioid overdose education, as well as two doses of an opioid antagonist and a prescription for an opioid antagonist. Additionally, upon commencement of treatment, admission, or discharge of an individual with a documented substance abuse disorder, including discharge from the emergency department, a hospital shall provide the patient with two doses of an opioid antagonist.

Legislative history

2019-20: S6650 Passed Senate; A8541 (Braunstein) referred to alcoholism and drug abuse

Fiscal implication

To be determined.

Effective date

This act shall take effect on the one hundred eightieth day after it shall become law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.